Form 4 for ADCT ADC Therapeutics SA
Accepted 2026-06-03 17:02:36 ET · period of report 2026-06-01 · accession 0001628280-26-040489 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-03 17:02 | 2026-06-01 | ADCT | Hug Peter | Dir | A - Grant | $0.00 | +45.0K | 265.5K | +20% | $0 | |
| 2026-06-03 17:02 | 2026-06-03 | ADCT | Hug Peter | Dir | F - Tax | $3.08 | -2,156 | 263.3K | -0.8% | -$6,640 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-06-01 | A | A | 45,000 | $0.00 | 265,500 | D | — | — | (F1) Represents the annual grant of restricted stock units ("RSUs") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest on the earlier of (i) one year from the grant date or (ii) the date of the 2027 Annual Meeting of Shareholders, subject to the Reporting Person's continued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Common | Common Shares | 2026-06-03 | F | D | 2,156 | $3.08 | 263,344 | D | — | — | (F2) Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted. |